TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 3 filers reported holding TG THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -63.6% | 900 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $22 | +57.1% | 900 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $14 | +27.3% | 900 | 0.0% | 0.00% | – |
| Q4 2022 | $11 | -99.8% | 900 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 900 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -77.8% | 900 | -52.6% | 0.00% | -100.0% |
| Q1 2022 | $18,000 | -88.4% | 1,900 | -76.7% | 0.00% | -85.7% |
| Q4 2021 | $155,000 | -22.9% | 8,140 | +34.8% | 0.01% | -30.0% |
| Q3 2021 | $201,000 | +58.3% | 6,040 | +84.6% | 0.01% | +66.7% |
| Q2 2021 | $127,000 | +101.6% | 3,272 | +151.7% | 0.01% | +100.0% |
| Q1 2021 | $63,000 | +293.8% | 1,300 | +333.3% | 0.00% | +200.0% |
| Q4 2020 | $16,000 | +23.1% | 300 | -40.0% | 0.00% | 0.0% |
| Q3 2020 | $13,000 | -31.6% | 500 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $19,000 | +90.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |